WO2001065263A2 - Sensor device for diarrhea diagnosis using fecal markers - Google Patents
Sensor device for diarrhea diagnosis using fecal markers Download PDFInfo
- Publication number
- WO2001065263A2 WO2001065263A2 PCT/US2001/006603 US0106603W WO0165263A2 WO 2001065263 A2 WO2001065263 A2 WO 2001065263A2 US 0106603 W US0106603 W US 0106603W WO 0165263 A2 WO0165263 A2 WO 0165263A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sensors
- detect
- sensor
- diarrhea
- causes
- Prior art date
Links
- 206010012735 Diarrhoea Diseases 0.000 title claims abstract description 38
- 230000002550 fecal effect Effects 0.000 title description 23
- 238000003745 diagnosis Methods 0.000 title 1
- 239000002699 waste material Substances 0.000 claims abstract description 38
- 230000036541 health Effects 0.000 claims abstract description 37
- 239000012491 analyte Substances 0.000 claims description 29
- 230000003612 virological effect Effects 0.000 claims description 13
- 230000001580 bacterial effect Effects 0.000 claims description 12
- 241000702670 Rotavirus Species 0.000 claims description 9
- 230000001717 pathogenic effect Effects 0.000 claims description 7
- 230000003287 optical effect Effects 0.000 claims description 6
- 241000607768 Shigella Species 0.000 claims description 4
- 241000701161 unidentified adenovirus Species 0.000 claims description 4
- 241000589875 Campylobacter jejuni Species 0.000 claims description 3
- 241000714209 Norwalk virus Species 0.000 claims description 3
- 241000607762 Shigella flexneri Species 0.000 claims description 3
- 241000607760 Shigella sonnei Species 0.000 claims description 3
- 241000607626 Vibrio cholerae Species 0.000 claims description 3
- 244000309743 astrovirus Species 0.000 claims description 3
- 229940118696 vibrio cholerae Drugs 0.000 claims description 3
- 210000003608 fece Anatomy 0.000 abstract description 25
- 235000016709 nutrition Nutrition 0.000 abstract description 15
- 201000010099 disease Diseases 0.000 abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 239000003550 marker Substances 0.000 abstract description 4
- 230000035764 nutrition Effects 0.000 abstract description 3
- 230000006870 function Effects 0.000 description 80
- 239000000463 material Substances 0.000 description 37
- 239000000126 substance Substances 0.000 description 34
- 230000004044 response Effects 0.000 description 26
- ZFRKQXVRDFCRJG-UHFFFAOYSA-N skatole Chemical compound C1=CC=C2C(C)=CNC2=C1 ZFRKQXVRDFCRJG-UHFFFAOYSA-N 0.000 description 20
- 238000012360 testing method Methods 0.000 description 19
- 102000004190 Enzymes Human genes 0.000 description 17
- 108090000790 Enzymes Proteins 0.000 description 17
- 229940088598 enzyme Drugs 0.000 description 17
- 239000010408 film Substances 0.000 description 16
- 241000894006 Bacteria Species 0.000 description 14
- 241000588724 Escherichia coli Species 0.000 description 14
- 239000002250 absorbent Substances 0.000 description 14
- 230000002745 absorbent Effects 0.000 description 14
- 239000000523 sample Substances 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- 230000007704 transition Effects 0.000 description 13
- 230000008859 change Effects 0.000 description 12
- 239000006260 foam Substances 0.000 description 12
- 239000012858 resilient material Substances 0.000 description 12
- 244000005700 microbiome Species 0.000 description 11
- 239000000758 substrate Substances 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- 238000005381 potential energy Methods 0.000 description 10
- 229940074386 skatole Drugs 0.000 description 10
- 210000002700 urine Anatomy 0.000 description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 9
- 239000011575 calcium Substances 0.000 description 9
- 229910052791 calcium Inorganic materials 0.000 description 9
- 239000002504 physiological saline solution Substances 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 241000700605 Viruses Species 0.000 description 8
- -1 etc.) Substances 0.000 description 8
- 239000000853 adhesive Substances 0.000 description 7
- 230000001070 adhesive effect Effects 0.000 description 7
- 244000052769 pathogen Species 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 206010040880 Skin irritation Diseases 0.000 description 6
- 244000052616 bacterial pathogen Species 0.000 description 6
- 230000002210 biocatalytic effect Effects 0.000 description 6
- 108091008690 chemoreceptors Proteins 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 230000004069 differentiation Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000000670 limiting effect Effects 0.000 description 6
- 244000000010 microbial pathogen Species 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 230000036556 skin irritation Effects 0.000 description 6
- 231100000475 skin irritation Toxicity 0.000 description 6
- 239000003053 toxin Substances 0.000 description 6
- 231100000765 toxin Toxicity 0.000 description 6
- 108700012359 toxins Proteins 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 229910001385 heavy metal Inorganic materials 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 244000045947 parasite Species 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 230000001960 triggered effect Effects 0.000 description 5
- 241000222122 Candida albicans Species 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 208000005374 Poisoning Diseases 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 230000027455 binding Effects 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 235000013350 formula milk Nutrition 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 231100000572 poisoning Toxicity 0.000 description 4
- 230000000607 poisoning effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- 241000193163 Clostridioides difficile Species 0.000 description 3
- 241000223935 Cryptosporidium Species 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000224467 Giardia intestinalis Species 0.000 description 3
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 3
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 3
- 241000725303 Human immunodeficiency virus Species 0.000 description 3
- 206010027439 Metal poisoning Diseases 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 229940095731 candida albicans Drugs 0.000 description 3
- 239000011111 cardboard Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 230000000112 colonic effect Effects 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 241001493065 dsRNA viruses Species 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 239000002532 enzyme inhibitor Substances 0.000 description 3
- 239000006261 foam material Substances 0.000 description 3
- 229940085435 giardia lamblia Drugs 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 235000003715 nutritional status Nutrition 0.000 description 3
- 239000006174 pH buffer Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000000246 remedial effect Effects 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 239000000592 Artificial Cell Substances 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 241000224432 Entamoeba histolytica Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010021639 Incontinence Diseases 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 206010025476 Malabsorption Diseases 0.000 description 2
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 102000018614 Uromodulin Human genes 0.000 description 2
- 108010027007 Uromodulin Proteins 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- HRBZRZSCMANEHQ-UHFFFAOYSA-L calcium;hexadecanoate Chemical compound [Ca+2].CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O HRBZRZSCMANEHQ-UHFFFAOYSA-L 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000009429 distress Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940007078 entamoeba histolytica Drugs 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229940047124 interferons Drugs 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 208000008127 lead poisoning Diseases 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 239000000123 paper Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 229920000247 superabsorbent polymer Polymers 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- CPBJMKMKNCRKQB-UHFFFAOYSA-N 3,3-bis(4-hydroxy-3-methylphenyl)-2-benzofuran-1-one Chemical compound C1=C(O)C(C)=CC(C2(C3=CC=CC=C3C(=O)O2)C=2C=C(C)C(O)=CC=2)=C1 CPBJMKMKNCRKQB-UHFFFAOYSA-N 0.000 description 1
- 241000588626 Acinetobacter baumannii Species 0.000 description 1
- 241000607528 Aeromonas hydrophila Species 0.000 description 1
- 206010001935 American trypanosomiasis Diseases 0.000 description 1
- 206010001986 Amoebic dysentery Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
- 241000606124 Bacteroides fragilis Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 241000589877 Campylobacter coli Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 208000024699 Chagas disease Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 241001112696 Clostridia Species 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 241000193466 Clostridium septicum Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 206010049119 Emotional distress Diseases 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000004262 Food Hypersensitivity Diseases 0.000 description 1
- 206010061958 Food Intolerance Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 241000224466 Giardia Species 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004125 Interleukin-1alpha Human genes 0.000 description 1
- 108010082786 Interleukin-1alpha Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 108010002386 Interleukin-3 Proteins 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 208000008763 Mercury poisoning Diseases 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 241000223960 Plasmodium falciparum Species 0.000 description 1
- 241000606999 Plesiomonas shigelloides Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000003391 RNA probe Substances 0.000 description 1
- 238000001069 Raman spectroscopy Methods 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
- 241000607726 Salmonella enterica subsp. enterica serovar Heidelberg Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 241000607766 Shigella boydii Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 101710084578 Short neurotoxin 1 Proteins 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 101710182532 Toxin a Proteins 0.000 description 1
- 241000223109 Trypanosoma cruzi Species 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 239000006035 Tryptophane Substances 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241000607447 Yersinia enterocolitica Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- MAEIEVLCKWDQJH-UHFFFAOYSA-N bumetanide Chemical compound CCCCNC1=CC(C(O)=O)=CC(S(N)(=O)=O)=C1OC1=CC=CC=C1 MAEIEVLCKWDQJH-UHFFFAOYSA-N 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 231100000020 developmental retardation Toxicity 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000741 diarrhetic effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 241001492478 dsDNA viruses, no RNA stage Species 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000000688 enterotoxigenic effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000020932 food allergy Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 244000000050 gastrointestinal parasite Species 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 235000021129 infant diet Nutrition 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000010808 liquid waste Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 108020004084 membrane receptors Proteins 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 210000000287 oocyte Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 229940115939 shigella sonnei Drugs 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000003812 trophozoite Anatomy 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- JFALSRSLKYAFGM-UHFFFAOYSA-N uranium(0) Chemical compound [U] JFALSRSLKYAFGM-UHFFFAOYSA-N 0.000 description 1
- 244000052613 viral pathogen Species 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 229940098232 yersinia enterocolitica Drugs 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/528—Atypical element structures, e.g. gloves, rods, tampons, toilet paper
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Definitions
- the present invention relates to devices having sensors adapted to detect and/or measure components of feces useful as health and/or nutritional indicators.
- devices comprising sensors to detect various disease or health conditions of individuals by analyzing blood for health markers are known.
- the most widely known include blood glucose monitors that allow patients with diabetes to monitor their blood glucose levels and determine the amount of insulin required to balance their sugar levels.
- portable devices with sensors adapted to detect alcohol (i.e., ethanol) levels in the exhaled breath of suspected intoxicated drivers are widely known and employed by various law enforcement agencies. These devices have generally replaced traditional laboratory testing as the preferred means for these applications because of their convenience and reliability.
- the devices respond to pre-defined target analytes in the blood and exhaled breath and provide an indication of the presence and/or level of the target analyte.
- the present invention is directed to a device that comprises a sensor adapted to detect one or more specific health and/or nutrition markers in feces.
- the device may also signal the caretaker of the occurrence or quantity of the marker.
- the device comprises a diagnostic panel including at least two sensors. The sensors are adapted to detect different target biological analytes in bodily waste or on the wearer's skin.
- the device of the present invention comprises a diagnostic panel adapted to determine the cause of a particular disease state, such as diarrhea, and to signal the caretaker, the wearer, or an actuator ofthe occurrence.
- Figure 1A is a plan view of a device made in accordance with the present invention adapted to be temporarily affixed to a subject's skin or a durable or disposable subject device, the device having sensors adapted to detect three different analytes and an indicator adapted to provide an indication ofthe presence of each analyte.
- Figure IB is a plan view of an alternative embodiment of the present invention.
- Figure 1C is a cross-sectional view of the device shown in Figure IB, taken through section lines lC-lC.
- Figure ID is a plan view of an alternative embodiment of the present invention.
- Figure IE is a cross-sectional view of the device shown in Figure IB, taken through section lines IE- IE.
- Figure 2 shows an alternate embodiment ofthe present invention.
- Figure 3 shows an alternate embodiment of the present invention.
- Figure 4 shows an alternate embodiment ofthe present invention.
- Figure 5 A shows an ideal output function of a discontinuous responsive system of the present invention having a single threshold level.
- Figure 5B shows an ideal output function of a discontinuous responsive system of the present invention having multiple threshold levels.
- Figure 6A shows an exemplary output function of a discontinuous responsive system of the present invention along with the first, second and third derivatives of the output function.
- Figure 6B shows a transfer function of a control system having a series of first order lags having an equal time constant.
- Figure 7 shows a perspective view of a bodily waste isolation device of the present invention in a compressed state before activation.
- Figure 7A shows a sectional view taken along line 7A-7A of Figure 7.
- the term “device” refers to devices or appliances which analyze bodily waste, particularly feces, for target chemical and/or biological analytes useful as health and/or nutritional markers.
- the device is generally reusable.
- reusable is used herein to describe devices which have at least one component which is not discarded immediately following its initial use, but which is employed in subsequent uses of the device. At least a portion of the device may be disposable.
- dispenser is used herein to describe absorbent devices which generally are not intended to be laundered or otherwise restored or reused (i.e., they are intended to be discarded after a single use).
- the device 20 preferably also includes at least one sensor 60 adapted to detect one or more health and/or nutritional markers in bodily waste and having the capability to provide a signal of said detection to the subject, caretaker, or an actuator.
- subject refers to a human whose waste is to be analyzed.
- caretaker refers to an individual responsible for the care of the subject, such as a nurse or a parent.
- medical personnel refers to individuals trained in a medically related field, such as doctors, nurses, and lab technicians. In certain instances, these terms may be used interchangeably.
- the subject may also be the caregiver, the caregiver may be a medical professional, etc..
- the term "sensor” refers to a device that is capable of detecting an event or a parameter that is associated with an event.
- a parameter associated with an event is any measurable signal that correlates with the occurrence of an event within the frame of reference of the system (i.e., a signal caused by the waste, the subject, or a component thereof).
- Sensors include anything that responds to one or more specific inputs.
- Sensors may be chemical, electrochemical, biochemical, or biological.
- the devices of the present invention specifically comprise sensors that provide a signal to the subject, caretaker and/or medical personnel indicating the presence and/or concentration of one or more health or nutritional markers in bodily waste such as feces, urine or menses.
- the signal may be an optical signal, including visual signals (e.g., a colorimetric or flourescent indicator), chemical signal (e.g., a change in pH, enzyme activity, or concentration of any other chemical species), or an electrical signal.
- Health markers and “nutritional markers” (e.g., in human feces), as used herein, refer to any elemental, chemical, or biological components that may be found in the waste, and any combinations of or relationships between (e.g., ratios, etc.) the components, having a defined relationship with the individual's health (e.g., disease, infection, poisoning, etc.) and nutritional status, respectively.
- the nutritional status of the subject includes, for example, metabolic efficiency, nutrient deficiencies, nutrient absorption or malabsorption, food and drink intake, food allergies (e.g., to peanuts), food intolerance (e.g., lactose intolerance), colonic bacteria ecology (e.g., beneficial bacteria such as bifidobacteria and lactobacillus), and total energy balance.
- food allergies e.g., to peanuts
- food intolerance e.g., lactose intolerance
- colonic bacteria ecology e.g., beneficial bacteria such as bifidobacteria and lactobacillus
- beneficial bacteria such as bifidobacteria and lactobacillus
- Health markers may include heavy metals (e.g., lead, mercury, etc.), radioactive substances (e.g., cesium, strontium, uranium, etc.), fats, enzymes, endogenous secretions, proteinaceous matter (e.g., casts), mucous, and microorganisms (described in more detail hereinafter in the biosensor section) that may be related to various health issues such as infection, diarrhea, gastrointestinal distress or disease, or poisoning. Heavy metals, especially in certain developing countries and in older and/or less affluent areas of developed countries, are a serious health risk.
- heavy metals e.g., lead, mercury, etc.
- radioactive substances e.g., cesium, strontium, uranium, etc.
- fats e.g., enzymes, endogenous secretions, proteinaceous matter (e.g., casts), mucous, and microorganisms (described in more detail hereinafter in the biosensor section) that may be related
- lead and mercury poisoning may occur upon the ingestion of these heavy metals from environmental sources (e.g., from lead paint, unregulated heavy industries, etc.) and can be fatal. More commonly, low-level poisoning by these and other heavy metals results in retarded intellectual and/or physical development, especially in children, that may occur over a long time and have lasting effects on the individual.
- Proteinaceous masses, such as casts e.g., in urine
- a suitable example of a sensor for Tamm-Horsfall protein is described in US Patent 5,780,239, which is incorporated herein by reference.
- Suitable sensors for heavy metals, and/or the discriminating means useful for the sensors are described more detail in US Patents 5,595,635; 5,865,972; 5,814,205; 5,468,366, all of which are incorporated herein by reference.
- Non-limiting examples of nutritional markers include calcium, vitamins (e.g., thiamine, riboflavin, niacin, biotin, folic acid, pantothenic acid, ascorbic acid, vitamin E, etc.), electrolytes (e.g., sodium, potassium, chlorine, bicarbonate, etc.), fats, fatty acids (long and short chain), soaps (e.g., calcium palmitate), amino acids, enzymes (e.g., lactose, amylase, lipase, trypsin, etc.), bile acids and salts thereof, steroids, and carbohydrates.
- vitamins e.g., thiamine, riboflavin, niacin, biotin, folic acid, pantothenic acid, ascorbic acid, vitamin E, etc.
- electrolytes e.g., sodium, potassium, chlorine, bicarbonate, etc.
- fats e.g., fatty acids (long and short chain), soaps (e.g., calcium palm
- the uncleaved palmitic acid binds calcium in the digestive tract as a soap (i.e., calcium palmitate) and leaves the body in the feces.
- a soap i.e., calcium palmitate
- the calcium and/or soap content in feces is one potential means of assessing calcium abso ⁇ tion by the digestive system.
- Suitable colorimetric calcium sensors based on Arsenazo III (acidic environment) and Cresolphthalein Complexone (basic environment) are available from Sigma-Aldrich Chemical of St. Lois, MO, as catalog numbers 588-3 and 587-A, respectively.
- Other exemplary sensors for calcium, and/or the discriminating means useful for the sensors are described more detail in US Patents 5,705,620; 5,580,441 ; and 5,496,522, all of which are inco ⁇ orated herein by reference.
- the sensors of the present invention may be associated with a carrier structure.
- the carrier structure may hold, stabilize, and/or at least partially encapsulate the sensor.
- carrier structures include one or more layers of elastic or inelastic woven and nonwoven webs, films, foams, scrims, hydrogels, and the like.
- the sensor may be attached to the carrier structure, held between two or more components, layers, or folds of the carrier structure, or may be sealed within the carrier structure.
- the carrier structure may optionally comprise an adhesive or skin adhering composition or other attachment means to secure at least a portion of said carrier structure to the device or a component thereof or to the subject's skin. Further, at least a portion of the carrier may be water soluble.
- the senor 60 may comprise a biosensor.
- biosensor is defined as a component comprising one or more biologically reactive means being adapted to detect one or more target pathogenic microorganisms or related biomolecules (e.g., an enzyme sensor, organella sensor, tissue sensor, microorganism sensor, immunosensor or electrochemical sensor),
- biologically reactive is defined as having the capability to selectively interact with, and preferably bind, target pathogenic microorganisms and/or related biomolecules as described herein.
- biosensors function by providing a means of specifically binding, and therefore detecting, a target biologically active analyte.
- the biosensor is highly selective, even when presented with a mixture of many chemical and biological entities, such as feces.
- the target biological analyte is a minor component of a complex mixture comprising a multiplicity of biological and other components.
- discrimination ratios of about 10 -10 or greater may be required for the biosensor to recognize the target biological analyte in a complex mixture.
- the biosensor of the present invention may comprise a bio-recognition element, or molecular recognition element, that provides the highly specific binding or detection selectivity for a particular analyte.
- the bio-recognition element, or system may be a biologically derived material such as an enzyme or sequence of enzymes; an antibody; a membrane receptor protein; DNA; an organelle, a natural or synthetic cell membrane; an intact or partial viable or nonviable bacterial, plant or animal cell; or a piece of plant or mammalian tissues, and generally functions to interact specifically with a target biological analyte.
- the bio-recognition element is responsible for the selective recognition of the analyte and the physico-chemical signal that provides the basis for the output signal.
- Biosensors may include biocatalytic biosensors, and bioaffmity biosensors.
- the bio-recognition element is "biocatalytic” and may comprise an enzyme, organelle, piece of plant or mammalian tissue, or whole cells, the selective binding sites "turn over" (i.e., can be used again during the detection process), resulting in a significant amplification of the input signal.
- Biocatalytic sensors such as these are generally useful for real-time, continuous sensing.
- Bioaffmity sensors are generally applicable to bacteria, viruses, and toxins and include chemoreceptor-based biosensors and/or immunological sensors (i.e. immunosensors).
- Chemoreceptors are complex biomolecular macroassemblies responsible, in part, for a viable organism's ability to sense chemicals in its environment with high selectivity.
- Chemoreceptor-based biosensors comprise one or more natural or synthetic chemoreceptors associated with a means to provide a signal (visual, electrical, etc.) of the presence or concentration of a target biological analyte.
- the chemoreceptor may be associated with an electrode (i.e., an electrical transducer) so as to provide a detectable electrical signal.
- Chemoreceptors may include whole or partial nerve bundles (e.g., from antennae or other sensing organs) and/or whole or partial natural or synthetic cell membranes.
- the bio-recognition elements of immunosensors are generally antibodies. Antibodies are highly specific and can be made toward bacteria, viruses, fragments of microorganisms (e.g., bacterial cell walls, parasite eggs or portions thereof, etc.), and large biomolecules. Suitable antibodies may be monoclonal or polyclonal. In any case, bioaffmity biosensors are generally irreversible because the receptor sites of the biosensor become saturated when exposed to the target biological analyte.
- biocatalytic bioaffmity biosensors may be combined, such as RNA/DNA probes or other high-affinity binding systems wherein the initial bio- recognition event is followed by biological amplification of the signal.
- a specific bacteria may be detected by a biosensor comprising genetic material, such as DNA, as a bio-recognition element and PCR (i.e., polymerase chain reaction) amplification to detect small numbers (e.g., less than or equal to 500) organisms.
- Biocatalytic and bioaffmity biosensor systems are described in more detail in Journal of Chromato raphy , 510 (1990) 347-354 and in the Kirk-Othmer Encyclopedia of Chemical Technology, 4 th ed. (1992), John Wiley & Sons, NY, the disclosure of which is inco ⁇ orated by reference herein.
- the biosensors of the present invention preferably detect biologically active analytes related to impending (i.e., future presentation of symptoms is likely) or current human systemic disease states, including, but not limited to, pathogenic bacteria, parasites (e.g., any stage of the life cycle, including eggs or portions thereof, cysts, or mature organisms), viruses, fungi such as Candida albicans, antibodies to pathogens, and/or microbially produced toxins. Additionally, the biosensor may target biologically active analytes related to impending or current localized health issues, such as stress proteins (e.g., cytokines) and IL-l ⁇ (interleukin 1 -alpha) that may precede the clinical presentation of skin irritation or inflammation.
- stress proteins e.g., cytokines
- IL-l ⁇ interleukin 1 -alpha
- the biosensor functions as a proactive sensor, detecting and signaling the subject, a caretaker or medical personnel of the impending condition prior to the presentation of clinical symptoms. This allows time to administer prophylactic or remedial treatments to the subject which can significantly reduce, if not prevent, the severity and duration of the symptoms.
- the sensor 60 by detecting the presence of a target biological analyte in the subject's bodily waste (e.g., feces), may detect residual contamination on a surface, such as skin or environmental surface, in contact with the biosensor, and provide and appropriate signal.
- the physico-chemical signal generated by the bio-recognition element or elements may be communicated visually to the caretaker or medical personnel (i.e., via a color change visible to the human eye as in a colorimetric sensor).
- Other embodiments may produce optical signals, which may require other instrumentation to enhance the signal.
- These include flourescence, bioluminesence, total internal reflectance resonance, surface plasmon resonance, Raman methods and other laser-based methods, such as LED or laser diode sensors.
- exemplary surface plasmon resonance biosensors are available as IBIS I and IBIS II from XanTec Analysensysteme of Muenster, Germany, which may comprise bioconjugate surfaces as bio-recognition elements.
- the signal may be processed via an associated transducer which, for example, may produce an electrical signal (e.g., current, potential, inductance, or impedance) that may be displayed (e.g., on a readout such as an LED or LCD display) or which triggers an audible or tactile (e.g., vibration) signal or which may trigger an actuator, as described herein.
- the signal may be qualitative (e.g., indicating the presence of the target biological analyte) or quantitative (i.e., a measurement of the amount or concentration of the target biological analyte).
- the transducer may optionally produce an optical, thermal or acoustic signal.
- the signal may also be durable (i.e., stable and readable over a length of time typically at least of the same magnitude as the usage life of the device) or transient (i.e., registering a real-time measurement). Additionally, the signal may be transmitted to a remote indicator site (e.g., via a wire, or transmitter, such as an infrared or rf transmitter) including other locations within or on the device or remote devices.
- a remote indicator site e.g., via a wire, or transmitter, such as an infrared or rf transmitter
- the senor 60 may be adapted to detect and/or signal only concentrations of the target biological analyte above a predefined threshold level (e.g., in cases wherein the target biological analyte is normally present in the bodily waste or when the concentration ofthe analyte is below a known "danger" level).
- a predefined threshold level e.g., in cases wherein the target biological analyte is normally present in the bodily waste or when the concentration ofthe analyte is below a known "danger" level.
- the target analytes that the biosensors of the present invention are adapted to detect may be pathogenic microorganisms such as the pathogenic microorganisms implicated in human gastrointestinal diseases, especially those resulting in diarrhea. This type of pathogen is particularly important to monitor due to the number of children who become seriously ill or die each year from diarrheal diseases. It has been found that severe chronic diarrhea may result in weight loss and permanent physical and mental developmental retardation.
- pathogenic bacteria that the sensor 60 may detect include any of the various pathogenic strains of Escherichia coli (commonly known as E. Coli), including enteropathenogenic E. coli (EPEC), enterotoxigenic E. coli (ETEC), enterohemorragic E.
- EHEC enteroinvasive E. coli
- EAEC enteroadherent E. coli
- Salmonella strains including S. typhi, S. paratyphi, S. enteriditis, S. typhimurium, and S. heidelberg
- Shigella strains such as Shigella sonnei, Shigella flexneri, Shigella boydii, and Shigella dysenteriae
- Vibrio cholerae Mycobacterium tuberculosis
- Yersinia enterocolitica Aeromonas hydrophila
- Campylobacter strains such as C. jejuni and C.
- Non-limiting examples of commercially available biosensors adapted to detect E. coli are available from AndCare, Inc. of Durham, NC, as test kit #4001 and from Meridian Diagnostics, Inc. of Cincinnati, OH, as ImmunoCard®STAT E. coli 0157 Plus assay.
- Another non-limiting example of a commercially available biosensor adapted to detect rotavirus is available from Meridian Diagnostics, Inc. of Cincinnati, OH, as 7ra/m ⁇ 77oCard®STAT! Rotavirus assay.
- Yet another non-limiting example of a commercially available biosensor adapted to detect cryptosporidium and giardia lamblia is available from Meridian Diagnostics, Inc. of Cincinnati, OH, as the Merifluor Crypto/Giardia assay.
- One more non-limiting example of a commercially available biosensor adapted to detect C. difficile toxin is available from Meridian Diagnostics, Inc. of Cincinnati, OH, as the Premier C. difficile Toxin A assay.
- ABT ⁇ CH, Scientific, Inc., of Yardley, PA offers "bioanalytical biotransducers", available as BB Au- 1050.5-FD-X, which may be rendered biospecific (for microorganisms or other target biological analytes as described herein) by covalently immobilizing polypeptides, enzymes, antibodies, or DNA fragments to their surfaces.
- the target analytes that the biosensors of the present invention are adapted to detect may also be viruses. These may include diarrhea-inducing viruses such as rotavirus, adenovirus (a dsDNA virus), astrovirus (an RNA virus), calcivirus (an RNA virus), and Norwalk viruses (RNA viruses), or other viruses such as rhinovirus and human immunodeficiency virus (HIV).
- a virus adenovirus
- astrovirus an RNA virus
- calcivirus an RNA virus
- RNA viruses Norwalk viruses
- HIV human immunodeficiency virus
- An exemplary biosensor adapted to detect HIV is described in US Patents 5,830,341 and 5,795,453, referenced above. The disclosure of each of these patents is inco ⁇ orated by reference herein.
- the target analytes that the biosensors of the present invention are adapted to detect may also be parasites, especially those which inhabit the gastrointestinal tract during some point in their life-cycle (e.g., eggs or portions thereof, oocytes, trophozoites, adults).
- parasites may include protozoans, worms, and other gastrointestinal parasites.
- Other examples of parasites which may be detected include entamoeba histolytica (which cause amoebic dysentery), cryptosporidium, giardia lamblia, and transomeba fragilis, trypana cruzi (which causes Chagas disease), and plasmodium falciparum .
- the target analytes the biosensors of the present invention are adapted to detect may fungi such as Candida albicans.
- certain beneficial colonic bacteria may be detected and/or measured as a health indicator, such as Bifidobacteria and Lactobacillus strains.
- the target analytes that the biosensors of the present invention are adapted to detect may also be proteins or antigens related to skin distress.
- these analytes are detectable on or at the skin surface, preferably prior to the presentation of clinically observable skin irritation.
- These may include stress proteins such as cytokines, histamine, and other immune response factors including interleukins (such as IL-l ⁇ , IL-2, IL-3, IL- 4, and IL-8) and interferons (including interferons a and g).
- these are preferably detectable by the sensor 60 prior to the onset of clinically observable redness, irritation, or dermatitis.
- the biosensors of the present invention may be adapted to detect enzymes, or other biological factors, implicated in skin irritation (e.g., diaper dermatitis), including tryspin, chymotrypsin, and lipase.
- the device may comprise a diagnostic panel.
- a "diagnostic panel”, as used herein, comprises two or more sensors each adapted to detect the presence of at least one pathogen. The sensors can be used to determine the class of pathogens or the specific pathogen(s) within a class causing a particular disease state.
- the diagnostic panel can be an effective means to help diagnose a disease state and help point a user or caretaker to a specific course of remedial medical treatment.
- the device may comprise a diagnostic panel adapted to determine the cause, or causes, of diarrhea such that the proper medication or medical treatment can be instituted.
- the diagnostic panel may provide an indication to the user of the presence of one or more of the most common viral causes of diarrhea.
- Such an device provides an indication alerting the user, caregiver, or health professional that the cause of the diarrhea is of viral nature.
- the diagnostic panel may comprise sensors adapted to detect at least two of the following group of viruses: rotavirus, adenovirus, astrovirus, calcivirus, and Norwalk viruses.
- the presence of any of the above viral causes of diarrhea are indicated by the diagnostic panel.
- the signal to the user, caretaker, or health professional from the diagnostic panel may indicate the specific viral cause of the diarrhea or may merely indicate that the cause is of viral nature.
- the article may comprise a diagnostic panel adapted to detect any of the potential bacterial causes of diarrhea.
- the diagnostic panel may comprise one or more sensors adapted to detect at least two of the following group of bacteria: EPEC, ETEC, EHEC, EAEC, EIEC, campylobacter jejuni, vibrio cholerae, and shigella strains, including S. sonnei and S. flexneri.
- the diagnostic panel be capable of detecting the presence of as many of the above bacterial causes of diarrhea as possible.
- the signal to the user, caretaker, or health professional from the diagnostic panel preferably indicates the specific cause (i.e., bacterial pathogen) of the diarrhea, allowing the early and specific treatment of the health condition.
- the article may comprise a diagnostic panel adapted to detect any of the potential viral and bacterial causes of diarrhea.
- the diagnostic panel may comprise one or more sensors adapted to detect at least one virus and one or more sensors adapted to detect at least one bacteria.
- the diagnostic panel be capable of detecting the presence of as many of the above bacterial and viral causes of diarrhea as possible.
- the signal to the user, caretaker, or health professional from the diagnostic panel preferably indicates the cause (i.e., viral or bacterial pathogen) of the diarrhea, allowing the early and specific treatment of the health condition.
- the article may comprise a diagnostic panel may be adapted to detect specific protozoan causes of diarrhea.
- the diagnostic panel may comprise at least one sensor adapted to detect one or more of the group: cryptosporidium, giardia lamblia, Swiss-Sha, and entamoeba histolytica.
- the diagnostic panel be capable of detecting the presence of as many of the above protozoan causes of diarrhea as possible.
- the signal to the user, caretaker, or health professional preferably indicates the specific protozoan causing the diarrhea, allowing the early and specific treatment of the health condition.
- the diagnostic panel may also be adapted to detect any combination of the pathogenic causes of diarrhea.
- the diagnostic panel may comprise one or more sensors adapted to detect a viral causes of diarrhea, one or more sensors adapted to detect bacterial causes of diarrhea and/or one or more sensors adapted to detect protozoan causes of diarrhea.
- FIG. IB- IE A non-limiting embodiment of an exemplary device 10 comprising a diagnostic panel 15 is shown in Figures IB- IE.
- the device 10 includes two sensors 12, sensor 14 adapted to detect E. coli HO 157 and a sensor 16 adapted to detect rotavirus. Both sensors 12 are disposed on substrate 18 which is comprised in the device 10.
- the substrate 18 is preferably a stiff cardboard material, although it may comprise any substrate such as paper, cardboard, a polyolefinic film, etc.
- the device 10 may also include a holder to reinforce any portion of the device 10. In such an embodiment, the holder may comprise a plastic holder having a slot, or set of slots, into which the substrate is placed.
- the device may be made by obtaining sensors from the hereinbefore mentioned 7mmw77oCard®STAT!
- E. coli 0157 Plus and 7ww ⁇ // ⁇ oCard®STAT! Rotavirus kits available from Meridian Diagnostics.
- the sensors are removed from their respective "cards” and attached to an exposed surface of the substrate 18 via any attachment or bonding means as known in the art, such as an adhesive.
- a mask 20 having openings corresponding to the sensors 12 may be applied to the surface of the substrate 18 to ensure fecal contact only with the sensors 12 themselves and not the remainder of the substrate 18 surface.
- the substrate 18, or mask 20 may be made of any material such as plastic, cardboard, or paper, and may comprise markings, instructions, or other indicia to aid in performance of the test or the inte ⁇ retation of the results.
- the substrate 18 may comprise a color change "key" to assist the user in the correct inte ⁇ retation of the results.
- the fecal sample may optionally be diluted with a diluent, such as the diluent provided with the ImmunoCard®STAT ⁇ kits, prior to application ofthe fecal sample to the sensors 12. This is especially helpful when the fecal sample is solid.
- the results from the sensors 12 may be read approximately 10 minutes after application of the fecal sample to the sensors or, if diluent was added, 10 minutes after the sample dilution.
- the above device 10 may also comprise an integral wiping mechanism 22 to remove excess feces from the sensors 12 to facilitate accurate inte ⁇ retation of the results.
- the wiping mechanism 22 may comprise a sliding bar including a flexible wiping flap having little or no clearance with the top surface of the sensor 12 that may be manually slid down the device 10 face to scrape excess feces from the sensor 12 surface.
- the sensor device 10 may be embodied in and/or on absorbent or non-absorbent articles such as diapers, incontinence undergarments, absorbent inserts, diaper covers, colostomy bags, wipes, towels, tissues, mops, bandages, feminine hygiene garments and the like.
- absorbent or non-absorbent articles such as diapers, incontinence undergarments, absorbent inserts, diaper covers, colostomy bags, wipes, towels, tissues, mops, bandages, feminine hygiene garments and the like.
- absorbent or non-absorbent articles such as diapers, incontinence undergarments, absorbent inserts, diaper covers, colostomy bags, wipes, towels, tissues, mops, bandages, feminine hygiene garments and the like.
- Patent 5,554,145 entitled “Absorbent Article With Multiple Zone Structural Elastic-Like Film Web Extensible Waist Feature” issued to Roe et al. on September 10, 1996;
- U.S. Patent 5,569,234 entitled “Disposable Pull-On Pant” issued to Buell et al. on October 29, 1996;
- U.S. Patent 6,004,306 entitled “Absorbent Article With Multi-Directional Extensible Side Panels” issued to Robles et al. on December 21 , 1999.
- Each of these patents is inco ⁇ orated herein by reference.
- Nonlimiting examples of feminine hygiene articles are disclosed in U.S.
- the combination of the sensors 12 provides a convenient means for diagnosing diarrhea based on common viral (rotavirus) and bacterial (E. coli) causes of diarrhea.
- the colorimetric sensor films described and claimed in U.S. Patent 6,001,556 adapted to detect rotavirus and E. coli, and optionally other diarrheal pathogens as described herein may be used in place of the Meridian Diagnostic 7 ww «oCard®STAT! sensors in the diaper embodiments described above. These films have the advantage of being thinner and smaller in area than many of the alternative sensor systems. It should additionally be noted that any of the other sensors described herein may be substituted or added to the foregoing examples, including both colorimetric and electrochemical sensors.
- the biosensors of the present invention may also comprise bio-recognition systems, including enzymes or binding proteins such as antibodies immobilized onto the surface of physico-chemical transducers.
- a specific strain of bacteria may be detected via biosensors employing antibodies raised against that bacterial strain.
- a target bacteria may be detected by a bio-recognition element (including antibodies and synthetic or natural molecular receptors) specific to extracellular products of the target bacteria, such as toxins produced by that strain (e.g., E. coli).
- Exemplary enzyme electrodes that may be used to detect phenols include tyrosinase based electrodes or polyphenol oxidase enzyme electrodes described in U.S.
- the specific microorganism may be directly detected or may be detected by binding a toxin, enzyme, or other protein produced by the organism or an antibody, such as a monoclonal antibody, specific to the organism.
- exemplary biosensors adapted to detect proteolytic enzymes are described in US Patent 5,607,567 and toxins in US Patents 5,496,452; 5,521,101 ; and 5,567,301.
- any of the sensors 60 of the present invention may comprise one or more "proactive sensors". This is especially useful in embodiments where the detection of the health and/or nutritional marker precedes the onset of clinically observable health symptoms.
- the term “proactive sensor” refers to a sensor that is capable of detecting changes or signals on the body of the individual (i.e., skin) or in bodily waste, i.e., inputs, that directly relate or, at a minimum, correlate to the occurrence of an impending or potential health or skin related event.
- Proactive sensors may respond to one or more specific inputs as described above.
- a proactive sensor 60 may detect an impending event or detect a parameter that directly relates, or at a minimum correlates to the occurrence of an impending event, particularly a systemic or skin health event (i.e., the presentation of clinically observable indications or symptoms).
- An impending event that may be detected or predicted by a proactive sensor 60 of the present invention may include early stages of lead poisoning, early stages of malnutrition and/or vitamin deficiency caused by nutrient malabso ⁇ tion, diarrheal disease, skin irritation or rash (including candidiasis), and/or other types of illness or medical conditions of the subject such as a parasitic infestation.
- the detected health and/or nutritional marker or biological analyte may be one or more steps removed from the actual presentation of clinical symptoms.
- the senor may detect potential precursors to the above conditions (e.g., fecal contamination of the skin that may precede the elicitation of stress proteins which may, in turn, precede clinically observable skin irritation).
- a parameter that correlates to an event is any measurable input, signal such as one or more of the potential inputs listed above, that correlates with the occurrence of the event within the frame of reference of the system (i.e., a signal caused by the waste or the subject).
- Proactive sensors 60 in an device may measure one or more different inputs in order to predict an event.
- the proactive sensor 60 may monitor for Candida albicans in the feces and residual colonic bacteria on the skin (i.e., detecting residual contamination) both of which are signals that may precede skin irritation.
- the sensor 60 may include a transducer in communication with the bio-recognition element in order to convert the physico chemical signal from the bio-recognition element into a usable signal to the subject, caretaker, or component of the device (e.g., and actuator).
- exemplary transducers may include electrochemical transducers (including potentiometric, amperometric, and conductimetric transducers), optical transducers (including flourescence, bioluminesence, total internal reflective resonance, and surface plasmon resonance), thermal transducers, and acoustic transducers, as known in the art.
- a power source such as a miniature 3 volt watch battery or printed thin film lithium battery, may be connected with the sensor 60 to provide any required power.
- the effectiveness of the biosensors of the present invention may be measured with the Response Factor Test described in the Test Method section below.
- the Response Factor describes the ratio of the response of the biosensor when exposed to fecal test material compared to the response of the biosensor when exposed to physiological saline solution and is useful in assessing the sensitivity of the biosensor for biologically active analytes expected to be found preferentially in feces versus urine.
- the biosensors of the present invention preferably have a response factor of at least 2, 3, or 5, more preferably at least 10, and even more preferably at least 20 when exposed to fecal test material in aqueous solution or test urine having a concentration of 1 gram of fecal test material per 1 gram of physiological saline solution.
- Biosensors are able to clearly distinguish between the presence of fecal material and the presence of physiological saline solution with respect to a target biologically active analyte specific to feces.
- skatole a substance commonly found in fecal material. It has been found that the skatole concentration in feces is about 180 microgram per gram of fecal material whereas the skatole level in urine has been found to be substantially lower. Skatole is generally a product of microbiological degradation that originates from the catabolism of tryptophane in the intestinal system.
- the biosensor comprises genetically engineered microorganisms which assimilate skatole and or other substances. The assimilation of skatole specific substances can be measured, for example, via the oxygen consumption during the assimilation process.
- Microorganisms suitable for detecting skatole include Acinetobacter baumannii TOI36 (FERM P-12891, Japanese patent publication JP05304947), and Bacillus sp TOI41(FREM P-12914, disclosed in Japanese patent publication JP05304948).
- Suitable biosensors including such microorganisms are commercially available for example from Institut fur Chemo- und Biosensorik of Minister, Germany, under the designation Mikrobielle Sensoren. If microorganisms are inco ⁇ orated into a biosensor, they may be immobilized in the biosensor by techniques known in the art such as entrapment, adso ⁇ tion, crosslinking, encapsulation, covalent attachment, any combination thereof, or the like. Further, the immobilization can be carried out on many different substrates such as known the art. In certain preferred embodiments, the immobilization substrate may be selected from the group of polymer based materials, hydrogels, tissues, nonwoven materials, woven materials.
- the senor 60 may comprise, be disposed on, or be operatively associated with a microchip, such as a silicon chip, MEMs (i.e., micro electromechanical system) device, or an integrated circuit.
- a microchip such as a silicon chip, MEMs (i.e., micro electromechanical system) device, or an integrated circuit.
- MEMs i.e., micro electromechanical system
- the microchip may comprise a multiplicity of sensor components having similar or different sensitivities, kinetics, and/or target analytes (i.e., markers) in an array adapted to detect differing levels or combinations of said analyte(s).
- each sensor in such an array may provide a different type of signal, including those types disclosed herein, and may be associated with different actuators and/or controllers.
- each sensor in an array may operate independently or in association with (e.g., in parallel, combination, or series) any number of other sensors in the array.
- any of the sensors 60 of the present invention may be disposed in and/or operatively connected to any portion of a device that will be exposed to the input that the sensor is designed to detect.
- the term "operatively connected” refers to a means of communication such that the sensor 60 may signal some portion of the device 20 when the sensor 60 detects an input.
- the sensor 60 may be separate from and operatively connected to another portion of the sensor 60, another sensor 60, an actuator, a controller or some other portion or component of the device 20.
- “Operatively connected” may, for example, include a means of communication such as an electrical connection via a conductive wire or member, via a transmitted signal such as radio frequency, infrared or another transmitted frequency communication.
- the senor 60 may be operatively connected via a mechanical connection such as a pneumatic or a hydraulic connection
- the sensor 60 may be integral with the device 20, or may be installed by the caretaker or medical personnel.
- the sensor during the course of the analysis, may also become at least partially detached from the device and may be adhered to the individual's skin (i.e., the patient or subject).
- the sensor may be affixed, permanently or detachably (e.g., via a mechanical fastening system like VelcroTM or a water soluble adhesive) to a support structure, including adhesive tapes, cellulosic or synthetic webs, nonwoven highlofts, films, scrims, foams, and the like.
- the senor 60 may be completely contained within the device such as device 20 or may have a receiving portion located in the device such that it will come into contact with the desired input and another portion such as a transmitting portion located either in the device or outside the device.
- the sensor 60 may be external to the device 20 yet operatively connected to some portion of the device 20 such that the sensor 60 may detect an input external to the device 20 and provide a signal to a controller and/or an actuator.
- the sensor may be separate from the device, e.g., separately applied to some portion of the subject via adhesive or other means as known in the art, and/or may have one or more components separate from the device.
- the device may be durable, such that it is completely reusable, or may be partially disposable, containing at least one disposable element.
- the device may comprise, or be used in conjunction with disposable components, elements, and/or articles, including disposal probes and/or probe covers, adhesive attachment means, carrier structures, power sources such as batteries, sensors or components thereof, and/or colorimetric or fluorescent test strips.
- the device of the present invention is adapted to detect health and/or nutritional markers in bodily waste, such as feces.
- the device, or component thereof may be wearable.
- Wearable devices or components may include elastic and other belts, disposable or durable clothing, disposable absorbent articles such as diapers, disposable waste-receiving articles such as colostomy bags, catheters, artificial stomas, adhesive or releasably attachable strips such as bandages and diagnostic strips, adhesively attached devices, and other wearable items as known in the art. Additionally, the device, or a component thereof may be releasably affixed to any of the above wearable articles or any other carrier structure that may be attached to the subject or a wearable article.
- FIG. 1A An adhesively attached wearable device is shown in Figure 1A.
- the embodiment of the device shown in Figure 1A comprises three sensors adapted to detect the presence of three different analytes and a display which is adapted to provide an indication of the presence of the analytes. (However, any number of sensors capable of detecting any number of different analytes is possible.)
- the sensors and display are affixed to a carrier which is releasably attached to a subject's skin via an adhesive.
- the device may be a handheld unit similar in size and shape to handheld electronic oral thermometers, a non-limiting example of which is shown in Figure 2.
- a sensor, or sensing system adapted to measure three different health and/or nutritional markers, is housed in one end of the device which is adapted for insertion into a body cavity or a waste sample.
- a display is disposed in the opposite end for convenient reading of the analysis of said markers.
- a disposable probe cover may be provided for hygienic use and easy cleaning.
- Figure 3 shows a similar embodiment adapted for use without a disposable probe cover.
- the device may be a table or benchtop or portable unit, such as is depicted in Figure 4.
- the device shown in Figure 4 comprises a sensor or sensing system adapted to measure or detect one or more of three different health and/or nutritional markers in bodily waste, as described above.
- the device may comprise as sensor element containing the sensor(s) attached via a data cable to the main body of the device.
- Disposable probe covers may be employed to provide hygienic use.
- Power for the device is preferably electrical in nature, although other power sources, such as mechanical, chemical, or electrochemical are contemplated. Electrical power may be provided as DC current, such as from a disposable or rechargeable battery, or AC current, such as from a generator or wall outlet. Embodiments are contemplated wherein the device is powered or the battery is recharged via solar energy.
- the signal provided by the device, or a component thereof, may be qualitative, such as an indication of the presence of a biological or chemical analyte, or quantitative, such as a concentration or relative amount, as described above.
- the output or signal may comprise a single signal, reading, or indication, or may comprise any number or combination of such outputs.
- the signal may be transient (i.e., in real time) or durable, such as a "peak" or "initial occurrence" reading.
- Passive contact is meant that the waste contacts at least a sensing portion of the device without any outside assistance by the caregiver or medical personnel.
- passive contact may occur in embodiments wherein at least a portion of said device, such as a sensor, is adhesively affixed to the subjects skin in the perianal region prior to the application of a diaper. In this case, the sensor would contact the waste as a result of the normal defecation process.
- active contact is meant that the subject, caregiver, or medical personnel may perform actions to bring about the contact of the waste and at least a sensing portion of the device.
- waste/device contact is active in an embodiment wherein a probe or sensor is manually inserted into a previously collected waste sample.
- the subject, caregiver, or medical personnel may be required to take a sample, or aliquot, of the waste or treat the waste to be analyzed with a preparatory treatment, such as a buffer or sterilization, prior to testing with the device of this invention.
- the device may release, inject, or treat the waste, or a sample thereof, with a reagent, buffer, stabilizer, indicator, or other analysis aid as is known in the art.
- a wiping means or element may be provided to allow the caretaker or medical personnel to clean sufficient bodily waste from the sensor 60 to allow a visual assessment or reading of the signal (especially for sensor embodiments that provide such a signal)
- the wiping element may include a web (cellulosic or synthetic), nonwoven highloft, film, foam, rigid or semi-rigid squeegee like element, and the like disposed in the device and adapted such that the element may be used to clean the sensor display
- the wiping element may be at least partially affixed the to a component of the device, such as a topsheet, in proximity to the sensor 60 by any known means in the art
- the wiping means may optionally comprise water or any other known cleaning aid to facilitate cleaning ofthe subject or the sensor display
- the device 20 also may comprise an actuator
- the term "actuator” refers to a device that comprises “potential” and a means of transforming that potential to perform or activate a "responsive function "
- the potential of the actuator may comprise either stored or potential energy or stored material The actuator thus may perform or activate a responsive function by transforming potential energy to kinetic energy or by releasing or delivering a stored material
- a "responsive function" is defined for the pu ⁇ oses of the present invention as a function performed upon the bodily waste, the subject, the device, or a component or components thereof, or a signal to the subject or the caretaker
- a component of bodily waste may include, for example, moisture, electrolytes, enzymes, volatile gases, bacteria, blood, etc
- a component of the subject may also include skin, genitaha, the anus, the anal sphincter muscle, etc
- Potential energy may be stored as mechanical, electrical, chemical or thermal energy "Kinetic energy” as used in this application refers to the capacity to do work or to perform
- the actuator of the present invention may release potential energy to perform or activate a responsive function upon the waste, the subject, the device, or a component thereof
- the release of potential energy may transform mechanical, electrical, chemical or thermal potential energy into mechanical, electrical or chemical kinetic energy to perform the responsive function.
- Actuators may be triggered by a threshold level of an input to release potential energy to perform a responsive function or may respond continuously to an input as described below.
- a compressed foam has stored compressive mechanical potential energy and may provide mechanical kinetic energy when it is released.
- a twisted foam has stored torsional mechanical potential energy that may provide mechanical kinetic energy, i.e., rotation, when it is released.
- stored chemical, electrical or thermal energy may be used to release electrical, mechanical, chemical or thermal kinetic energy.
- the actuator of a device may include one or more of the following: stored lotion, anti-fungal or antimicrobial agents, feces modification agents, enzyme inhibitors, pH buffers, dyes, pressurized gas, a compressed foam, a twisted foam, a pump, a closed system liquid transport member, an electrically sensitive gel, a pH sensitive gel, a salt concentration gel, etc.
- Potential energy may be stored in any manner sufficient to maintain or restrain it until it is required.
- Suitable means for maintaining and/or restraining such energy include batteries and/or capacitors, elastically, torsionally, compressively tensioned materials or structures in the form of unreacted reagents, and materials capable of performing physical or chemical functions (e.g., absorbents, emollients, pH buffers, enzyme inhibitors, feces modification agents; compressed gases, etc.).
- the actuator of the present invention may comprise a quantity of a stored material that has the capacity to perform or activate a responsive function upon the waste, the subject, the device, or any component or components thereof. In one embodiment, for example, the actuator may release or deliver a stored material that performs a responsive function.
- the actuator may be triggered by a threshold level of an input to discontinuously release or deliver the stored material at a given time or may release or deliver the material continuously.
- the actuator may, for example, include stored lotion, skin care compositions, antifungal or antimicrobial agents, feces modification agents, enzyme inhibitors, pH buffers, dyes, etc.
- the material may be delivered by an actuator such as an expanding resilient material, a released high pressure gas, etc.
- Figures 7 and 7A illustrate an actuator 90 comprising a compressed resilient material 94, such as a foam, sealed under at least a partial vacuum within a pressure differentiation device 91.
- a pressure differentiation device is any device or structure that can maintain a resilient material in a compressed state (e.g., can store energy by providing a constraining pressure on the compressed resilient material 94).
- a "compressed state” is defined as the condition in which a material is maintained at a smaller volume than the material would have if unconstrained and under zero applied pressure.
- resilient materials a compressed state may generally be achieved by applying a pressure to a surface of the material or via any other means known in the art.
- the pressure differentiation device may, for example, comprise a vacuum sealed bag or tensioned materials, such as elastic or inelastic bands or strands, strips, films, nonwoven, scrims, or foams, that constrain a resilient material.
- the compression of the resilient material maintained by the pressure differentiation device 91 may be at least partially reduced (i.e., the compressed resilient material 94 may at least partially expand) via a trigger mechanism.
- a trigger mechanism is any element or device, such as a sensor, actuator, or combination thereof, that responds to an input to effect the equalization of pressure in the pressure differentiation device 91 and allow the compressed resilient material 94 to at least partially expand.
- the compressed resilient material may expand and deliver the stored material.
- the actuator may comprise a void space 96.
- the resilient material may comprise any resilient material, including but not limited to, an EVA foam such as the ones available from Foamex Co ⁇ oration of Eddystone, Pennsylvania identified as SIF/210PP1 or Aquazone 80A foam, or from Sentinel Products Co ⁇ oration of Hyannis, MA identified as MCI 900 EVA 2 lb/ft 3 , or a HIPE foam as described in United States Patent No. 5,260,345 entitled "Absorbent Foam Materials For Aqueous Body Fluids and Absorbent Articles Containing Such Materials" issued to DesMarais et al. on November 9, 1993; United States Patent No.
- the soluble bag may be soluble in the presence of one or more different types of input, such as water, urine, fecal enzymes, a pH level, etc., and may have physical and/or chemical characteristics (e.g., thickness) that may be designed to set a threshold level of that input required to dissolve the bag.
- the soluble bag may, for example, comprise a plastic film that is soluble to water such as PVA films supplied by Chris-Craft Industrial Products, Inc. of South Holland, IL as MONOSOL M7031, M7030, M8630, M8534, or E6030 film, or H. B. Fuller Company of St. Paul, MN as HL 1636 or HL 1669-X.
- the film thickness may also be modified to provide a desired activation.
- the film used may, for example, also have a thickness in the range from about 0.0005 to about 0.0015 inches.
- An HL 1636 film having a thickness of about 0.001 inches, for example, will activate with a moisture content of about 0.049 grams per square inch.
- the actuator may be disposed in and/or operatively connected to any portion of the device that will allow the actuator to perform a responsive function upon the bodily waste, the subject, the device, or a component thereof.
- the device 20 may also include a controller.
- a "controller” is defined for the pu ⁇ oses of this application as a device that receives an input from a sensor and determines if one or more actions are to be taken.
- the controller may receive a signal from the sensor 60 and direct the actuator to perform a responsive function upon the bodily waste, the subject, the device or a component thereof.
- the actuator may receive the signal directly from the sensor 60 and perform a responsive function upon the subject, the waste, the device or a component thereof.
- the controller may include materials that undergo chemical or physical change, may be a chemical, mechanical or electrical device that processes information from a sensor, etc.
- the biosensor 60 may comprise a transducer comprising a polylayer Langmuir-Blodgett film, at least a portion of which may function as a controller, wherein one or more layers includes a bio-recognition element.
- a transducer comprising a polylayer Langmuir-Blodgett film, at least a portion of which may function as a controller, wherein one or more layers includes a bio-recognition element.
- Langmuir-Blodgett films Upon contact with water, Langmuir-Blodgett films are known to spontaneously reorganize, resulting in regions with more layers than the original film and other regions having fewer layers. This reorganization may expose the bio-recognition element to the environment preferentially in the presence of water, such as in bodily waste, which may contain the target biological analyte. This may reduce false positives and/or extend the shelf-life of the biosensor.
- an electrical controller that
- the controller may be completely contained within the device such as device 20, may have a portion located in the device and a portion located outside the device, or may be located completely outside the device 20.
- the controller or a portion of a controller may be operatively connected to one or more sensors 60, one or more actuators 90, another portion of the controller or another portion of the device 20.
- the controller may receive a signal from the sensor 60 and provide a signal to the actuator, e.g., by a radio frequency (rf) transmission.
- rf radio frequency
- the sensor 60, actuator and controller functions may perform the sensor 60, actuator and controller functions, the sensor 60, actuator and/or controller functions of the present invention need not be performed by distinct structural elements.
- the sensor 60 and controller functions may be performed by the same structural element.
- a "responsive system” is defined for the pu ⁇ oses of this application as a system that includes a sensor 60 and an actuator that acts upon the bodily waste, the subject, the device, or a component or components thereof when the sensor 60 detects the appropriate triggering input.
- the actuator effects the release of stored energy or the release or delivery of stored material to perform a responsive function.
- a proactive sensor 60 including a transducer detects an impending event
- the transducer provides a signal to the actuator effecting the release of stored energy.
- a responsive system in the device may be triggered to prepare for the event or to signal the caregiver or the subject of the impending event.
- the sensor 60 in these embodiments may trigger an actuator to perform an action on the device, the subject or the environment to prepare for the occurrence of the event or provide a signal to the caregiver that the impending event is about to occur.
- the sensor 60 comprises a sensing system, one actuator may be triggered by different sensors and/or signals, or different actuators may be triggered by different sensors and/or signals. Alternatively, one sensor and/or signal may trigger multiple actuators.
- a responsive system may respond in either a “continuous” or a “discontinuous” manner.
- a “continuous responsive system” refers to a responsive system in which the output is quantitatively dependent upon the quantity of the input, i.e., continuously increasing quantities of the input are required to effect continuously increasing quantities of the output, or where the output of the responsive system comprises a passive release of a stored material.
- a super absorbent polymer placed in an absorbent core of an device provides a continuous response in which the output is quantitatively dependent upon the quantity of the input, i.e., as increasing quantities of liquid waste contact the super absorbent polymer, an increasing amount of the polymer contains that liquid until the capacity of the polymer is exhausted.
- a stoichiometric chemical reaction is another example of a system having a continuous response to increasing output.
- a + excess B — > C for example, the amount of excess B converted to C is stoichiometrically and, therefore "continuously,” related to the amount of A available in the system.
- a “discontinuous responsive system” of the present invention refers to a responsive system that has an output function that is essentially independent of the quantity of the input beyond a threshold level. For example, when one or more threshold levels of a given input are met, the responsive system may release all or a pre-designated portion of its stored energy or deliver, i.e., actively transport, all or a pre-designated portion of its stored material to perform a specific responsive function.
- the output function, f(x) includes a "step" function as shown in Figure 5A.
- the rate of change in the output with increasing levels of input d(output)/d(input)
- the slope or first derivative f (x) of the output function f(x) is preferably essentially zero when the amount of input is above or below the threshold level.
- the d(output)/ d(input) rate of change preferably approaches infinity.
- the limit of the function f(x- ⁇ ) as ⁇ O is not equal to the limit of the function f(x+ ⁇ ) as ⁇ O, i.e., lim f(x- ⁇ ) ⁇ lim f(x+ ⁇ ).
- the present invention recognizes that in the physical world an ideal instantaneous step change at the threshold level is not necessary and may not even be possible in many instances. In a preferred embodiment, it is only necessary that the output function have a virtual step change with very little change in the input at or around the threshold level ofthe input.
- the present invention contemplates a discontinuous responsive system of the present invention having an output function that responds in a sufficiently discontinuous manner in the transition region such that the output function has at least a minimum relative degree of steepness in the transition region.
- the slope of the output curve at the inflection point is compared with the relative slope of a line between the first and last points of the transition region.
- Figure 6A shows a graph of an exemplary output function, f(x) along with aligned graphs of the first, f (x), and second, f '(x), and third, f "(x), derivatives of the exemplary output function.
- the output function f(x) describes the effect of the in put (x or I) on the output or response (R(I)).
- the transition region is defined as the region between the relative maxima, R(L), and the minima, R(L), of the second derivative, f '(x), of the output function, f(x).
- the relative maxima, R(L), and the relative minima, R(l2), are points at which the third derivative, f "(x), equals zero.
- the inflection point, lo is defined as the point in the transition region at which the second derivative, f '(x), equals zero, i.e., d 2 R
- dR/dl at the inflection point is the first derivative of the output function at that point.
- ⁇ I ⁇ is the change in the input to the responsive system between the first, I
- ⁇ R ⁇ is the change in the response of the output function between the first and last points of the transition region, i.e., R(h) - R(D-
- the coefficient k is a proportional constant that describes the relative steepness of the slope of the output function at the inflection point, lo, compared to the slope of a line between the first and last points of the transition region.
- the proportional constant k must be at least about 2.0, preferably at least about 3.0, more preferably at least about 5.0, even more preferably at least about 10.0, with at least about 100.0 being the most preferred.
- the relative degree of steepness in the transition region of a discontinuous responsive system may also be modeled by a transfer function of a control system having a series of an integer number, n, first order lags with an equal time constant.
- the transfer function of the responsive system is defined for the pu ⁇ oses of the present invention as the ratio of the Laplace transforms of the output (responding variable) to the input (disturbing variable). See, e.g., Robert H.
- KG(s) K/(Ts + l) n in which KG(s) is the transfer function, K is a proportional element, T is the time constant of the system, and n is the integer number of first order time lags.
- n is the integer number of first order time lags.
- Certain discontinuous responsive systems of the present invention preferably may be modeled by the above formula when n is greater than or equal to about 25, with n being greater than or equal to about 50 being more preferred, and n being greater than or equal to about 100 being the most preferred.
- a responsive system of the present invention may include a single threshold level at which the responsive system may release all of its stored energy to perform a specific responsive function or may include multiple threshold levels at which the system may release a pre-designated portion of its stored energy to perform one or more specific responsive functions at each of the threshold levels.
- the responsive system may release all of its stored energy to perform the entire responsive function when that threshold level is met.
- the discontinuous responsive system includes a system that has two states such as on or off.
- the responsive system may perform a single responsive function upon the waste, the subject, the device or a component thereof, such as providing an easily detectable visual signal to the subject or caregiver.
- the discontinuous responsive system may perform a one-time "switch-like" function that changes from one state to another in the presence of a threshold level of an input.
- the responsive system may have multiple threshold levels at which when each threshold level is met the system may release a given "quanta" of energy or deliver a given quantity of material to perform a specific responsive function.
- the responsive system when each threshold level is met, a portion of the entire responsive function may be performed and/or different independent responsive functions may be performed in response to different threshold levels being met.
- the responsive system responds essentially the same as the transition region in the single threshold embodiment described above.
- a responsive system may monitor multiple inputs such as one or more pathogenic bacteria and/or one or more fecal enzymes and perform one or more responsive functions when the threshold levels of the different inputs are met or may perform one responsive function only when two or more of the threshold levels of the different inputs are met.
- a controller may monitor multiple different inputs and perform a different responsive function when the threshold level of the different inputs are met.
- the controller may perform a logic OR-gate type function such that a responsive function may be performed when one or more threshold levels of the multiple inputs are met.
- the controller may also perform a logic AND-gate type function such that a responsive function may be performed when each threshold level of two or more different inputs is met.
- the responsive system may also comprise a "closed loop” or an "open loop” system.
- a "closed loop” system which is also referred to as a “feedback control loop” system, includes distinct sensor 60 and actuator components and performs a responsive function upon the input.
- the system may also use a detection or a measurement of an element or a parameter of the output condition as at least one trigger of the responsive function that is performed upon the input.
- the output condition may be the state of the input condition after the actuator has had the opportunity to perform a responsive function on the input condition.
- the responsive function may be performed when the output condition reaches a threshold level, or may be performed only when the output condition and one or more other conditions are met.
- Acting upon the input may include acting upon the element sensed, e.g., sensing a microorganism and acting upon the microorganism, or may include acting upon a composition of which the element sensed is an integral component, e.g., sensing a fecal bacteria and acting upon the fecal mass or residual feces on the subject's skin
- a feedback control loop system includes at least two distinct components: the sensor 60 and the actuator.
- the sensor 60 detects an event, or a parameter associated with that event.
- the actuator receives a signal and performs a responsive function on the input condition detected by the sensor 60.
- the feedback control loop may further include a controller.
- the sensor 60 may provide a signal to the controller, and the controller may direct the actuator to perform a responsive function upon the input condition.
- the controller may be a separate component of the responsive system or the controller function may be performed by the sensor 60 and/or the actuator.
- the feedback control loop may be "non-modulating" or “modulating.”
- a “non- modulating" feedback control loop responsive system the responsive system acts as a one-time switch in which the actuator performs a responsive function on the input when the threshold level of the output condition is met.
- the sensor 60 may detect the presence of or measure the concentration of a specific pathogenic microorganism, and the actuator may signal the caretaker of a potential incipient infection. In this example, the actuator acts upon the input detected by the sensor 60.
- a “modulating" feedback control loop includes a sensor 60, an actuator and a controller.
- an "open loop" system is a system that responds to the input to perform a responsive function without using feedback, i.e., the output has no effect upon the sensed input entering the system.
- An open loop system may include a responsive system that has a single device that performs the functions of both the sensor 60 and the actuator or may have distinct sensor 60 and actuator components in which the actuator acts upon something other than the input.
- an open loop responsive system may include a sensor 60 that detects bodily waste or a component of that bodily waste, and an actuator that performs a responsive function in a continuous or a discontinuous manner on something other than the input detected by the sensor 60.
- the specific substances or compositions for which this test is suitable are: fecal test material in aqueous solution having a concentration of 1 gram of fecal test material per 1 gram of physiological saline solution; fecal test material in test urine solution having a concentration of 1 gram of fecal material per 1 gram of test urine solution; test urine solution; a solution of skatole in physiological saline solution having a concentration of 180 micrograms of skatole per gram of physiological saline solution; and physiological saline solution.
- the Response Factor is obtained by normalizing the substance response with the background response. In case, the thus obtained Response Factor is smaller than 1 , the reciprocal value of the Response Factor is reported as the Response Factor.
- the present invention may also include sensors and detectors, and methods of using the same, that are employed for a particular pu ⁇ ose that has not been known previously, regardless of whether they are on an article of a specific type and regardless of whether they are used alone, or in the context of a diagnostic panel with other sensors. Therefore, the appended claims are intended to cover all such changes and modifications that are within the scope of this invention.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01914606A EP1261869A2 (en) | 2000-03-02 | 2001-03-01 | Sensor device for diarrhea diagnosis using fecal markers |
JP2001563907A JP2003525453A (en) | 2000-03-02 | 2001-03-01 | Device with diarrhea diagnostic panel |
AU2001239972A AU2001239972A1 (en) | 2000-03-02 | 2001-03-01 | Device having diarrhea diagnostic panel |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/517,827 US6436055B1 (en) | 2000-03-02 | 2000-03-02 | Device having diarrhea diagnostic panel |
US09/517,827 | 2000-03-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001065263A2 true WO2001065263A2 (en) | 2001-09-07 |
WO2001065263A3 WO2001065263A3 (en) | 2002-04-04 |
Family
ID=24061388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/006603 WO2001065263A2 (en) | 2000-03-02 | 2001-03-01 | Sensor device for diarrhea diagnosis using fecal markers |
Country Status (6)
Country | Link |
---|---|
US (1) | US6436055B1 (en) |
EP (1) | EP1261869A2 (en) |
JP (1) | JP2003525453A (en) |
AR (1) | AR027594A1 (en) |
AU (1) | AU2001239972A1 (en) |
WO (1) | WO2001065263A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7002054B2 (en) | 2001-06-29 | 2006-02-21 | The Procter & Gamble Company | Absorbent article having a fever indicator |
US7365238B2 (en) | 2002-02-19 | 2008-04-29 | The Procter And Gamble Company | Absorbent article having a dehydration indicator |
FR3037656A1 (en) * | 2015-06-16 | 2016-12-23 | Phoenix Clinical Res Sal | METHOD OF EVALUATING THE RISK OF CONTRACTING TRAVELER DIARRHEA AND KIT FOR CARRYING OUT SAID METHOD |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6617488B1 (en) * | 1997-10-14 | 2003-09-09 | Indicator Technologies, Inc. | Method and apparatus for indicating the conditions in an absorbent article |
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
DE20001141U1 (en) * | 2000-01-24 | 2000-04-27 | Buzluhan, Hülya, 90427 Nürnberg | Women's panty liner, especially for pregnant women |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
JP4209767B2 (en) | 2001-06-12 | 2009-01-14 | ペリカン テクノロジーズ インコーポレイテッド | Self-optimized cutting instrument with adaptive means for temporary changes in skin properties |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
WO2002100460A2 (en) | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Electric lancet actuator |
US7041068B2 (en) | 2001-06-12 | 2006-05-09 | Pelikan Technologies, Inc. | Sampling module device and method |
US7749174B2 (en) | 2001-06-12 | 2010-07-06 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US6917926B2 (en) * | 2001-06-15 | 2005-07-12 | Medical Scientists, Inc. | Machine learning method |
US7141662B2 (en) * | 2001-11-30 | 2006-11-28 | University Of Maryland, Baltimore | Nucleic acids encoding novel proteins in enteroaggregative Escherichia coli (EAEC) |
US7407570B2 (en) * | 2002-03-13 | 2008-08-05 | The Charles Stark Draper Laboratory, Inc. | Disposable, self-administered electrolyte test |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7708701B2 (en) | 2002-04-19 | 2010-05-04 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7175642B2 (en) | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8372016B2 (en) | 2002-04-19 | 2013-02-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US6780653B2 (en) | 2002-06-06 | 2004-08-24 | Micron Technology, Inc. | Methods of forming magnetoresistive memory device assemblies |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
WO2004107975A2 (en) | 2003-05-30 | 2004-12-16 | Pelikan Technologies, Inc. | Method and apparatus for fluid injection |
WO2004107964A2 (en) | 2003-06-06 | 2004-12-16 | Pelikan Technologies, Inc. | Blood harvesting device with electronic control |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
EP1706026B1 (en) | 2003-12-31 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
EP1765194A4 (en) | 2004-06-03 | 2010-09-29 | Pelikan Technologies Inc | Method and apparatus for a fluid sampling device |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
WO2006021214A2 (en) * | 2004-08-24 | 2006-03-02 | Rådet For Agroindustri | A method and an apparatus for determining pregnancy of animals |
US20060223053A1 (en) * | 2004-11-09 | 2006-10-05 | Roper D K | Direct measurement of sorption on three-dimensional surfaces such as resins, membranes or other preformed materials using lateral dispersion to estimate rapid sorption kinetics or high binding capacities |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
CN101532980B (en) * | 2009-04-16 | 2012-07-18 | 浙江工商大学 | Enzyme immunosensor for detecting Shigella species and its preparation method and application |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8973565B2 (en) * | 2011-08-09 | 2015-03-10 | The United States Of America As Represented By The Secretary Of The Army | Device and method for inducing brain injury in animal test subjects |
WO2014066913A2 (en) | 2012-10-26 | 2014-05-01 | Pixie Scientific, Inc | Health diagnostic systems and methods |
EP3298401A4 (en) | 2015-05-22 | 2019-01-16 | Pixie Scientific, LLC | Indicator panels for incontinence products |
BR112020017257A2 (en) * | 2018-03-29 | 2020-12-22 | Kimberly-Clark Worldwide, Inc. | SENSOR, ABSORBENT ARTICLE, AND METHOD TO INDICATE A POTENTIAL SKIN OR GASTROINTESTINAL PROBLEM. |
JP7147450B2 (en) * | 2018-10-12 | 2022-10-05 | 東洋インキScホールディングス株式会社 | Excretion state analysis system |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5354661A (en) * | 1990-07-27 | 1994-10-11 | Wisconsin Alumni Research Foundation | Monoclonal antibody to enterohemorrhagic Escherichia coli 0157:H7 and 026:H11 and method for detection |
US5795717A (en) * | 1994-02-28 | 1998-08-18 | Shimadzu Corporation | Oligonucleotides for detecting bacteria and detection process |
US5830341A (en) * | 1996-01-23 | 1998-11-03 | Gilmartin; Markas A. T. | Electrodes and metallo isoindole ringed compounds |
US6001556A (en) * | 1992-11-13 | 1999-12-14 | The Regents Of The University Of California | Polymeric assay film for direct colorimetric detection |
WO2000000233A1 (en) * | 1998-06-29 | 2000-01-06 | The Procter & Gamble Company | Disposable article having bodily waste component sensor |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ306051A (en) * | 1995-03-10 | 1999-11-29 | Meso Scale Technologies Llc | Testing using electrochemiluminescence |
CA2254119A1 (en) * | 1996-05-10 | 1997-11-20 | The Victoria University Of Manchester | Sample analyser |
US5922550A (en) * | 1996-12-18 | 1999-07-13 | Kimberly-Clark Worldwide, Inc. | Biosensing devices which produce diffraction images |
US6117643A (en) * | 1997-11-25 | 2000-09-12 | Ut Battelle, Llc | Bioluminescent bioreporter integrated circuit |
EP1091718B1 (en) * | 1998-06-29 | 2007-09-05 | The Procter & Gamble Company | Disposable treatment article having a responsive system |
JP2000024023A (en) * | 1998-07-13 | 2000-01-25 | Reoro Kk | Sensor for diaper, manufacture thereof, and diaper attached with the same |
US6251083B1 (en) * | 1999-09-07 | 2001-06-26 | Amira Medical | Interstitial fluid methods and devices for determination of an analyte in the body |
-
2000
- 2000-03-02 US US09/517,827 patent/US6436055B1/en not_active Expired - Lifetime
-
2001
- 2001-03-01 WO PCT/US2001/006603 patent/WO2001065263A2/en active Application Filing
- 2001-03-01 JP JP2001563907A patent/JP2003525453A/en active Pending
- 2001-03-01 AU AU2001239972A patent/AU2001239972A1/en not_active Abandoned
- 2001-03-01 EP EP01914606A patent/EP1261869A2/en not_active Withdrawn
- 2001-03-02 AR ARP010100995A patent/AR027594A1/en not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5354661A (en) * | 1990-07-27 | 1994-10-11 | Wisconsin Alumni Research Foundation | Monoclonal antibody to enterohemorrhagic Escherichia coli 0157:H7 and 026:H11 and method for detection |
US6001556A (en) * | 1992-11-13 | 1999-12-14 | The Regents Of The University Of California | Polymeric assay film for direct colorimetric detection |
US5795717A (en) * | 1994-02-28 | 1998-08-18 | Shimadzu Corporation | Oligonucleotides for detecting bacteria and detection process |
US5830341A (en) * | 1996-01-23 | 1998-11-03 | Gilmartin; Markas A. T. | Electrodes and metallo isoindole ringed compounds |
WO2000000233A1 (en) * | 1998-06-29 | 2000-01-06 | The Procter & Gamble Company | Disposable article having bodily waste component sensor |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7002054B2 (en) | 2001-06-29 | 2006-02-21 | The Procter & Gamble Company | Absorbent article having a fever indicator |
US7365238B2 (en) | 2002-02-19 | 2008-04-29 | The Procter And Gamble Company | Absorbent article having a dehydration indicator |
FR3037656A1 (en) * | 2015-06-16 | 2016-12-23 | Phoenix Clinical Res Sal | METHOD OF EVALUATING THE RISK OF CONTRACTING TRAVELER DIARRHEA AND KIT FOR CARRYING OUT SAID METHOD |
Also Published As
Publication number | Publication date |
---|---|
AU2001239972A1 (en) | 2001-09-12 |
AR027594A1 (en) | 2003-04-02 |
EP1261869A2 (en) | 2002-12-04 |
US6436055B1 (en) | 2002-08-20 |
WO2001065263A3 (en) | 2002-04-04 |
JP2003525453A (en) | 2003-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6436055B1 (en) | Device having diarrhea diagnostic panel | |
US6342037B1 (en) | Device having fecal component sensor | |
US6479727B1 (en) | Diagnostic panel | |
US6399853B1 (en) | Disposable article having fecal component sensor | |
US7982088B2 (en) | Disposable article having a biosensor | |
CA2336025C (en) | Disposable article having bodily waste component sensor | |
WO2000065348A2 (en) | Disposable articles and other articles comprising a detection device | |
WO2000000822A1 (en) | Device having fecal component sensor | |
EP1092151B1 (en) | Device having fecal component sensor | |
JP2003524756A6 (en) | Device with stool component sensor | |
EP1091773B1 (en) | Disposable article having bodily waste component sensor | |
KR20010053327A (en) | Disposable article having bodily waste component sensor | |
MXPA00012991A (en) | Device having fecal component sensor | |
TW476640B (en) | Disposable article, article for detecting the presence of vaginal infections, and absorbent interlabial device | |
TW421587B (en) | Disposable article having bodily waste component sensor | |
TW467736B (en) | Feminine sanitary disposable article having a blood detection means as sensor | |
KR20020000877A (en) | Feminine sanitary disposable article having a blood detection means as sensor | |
MXPA00012993A (en) | Disposable article having bodily waste component sensor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 563907 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001914606 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001914606 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |